10x Genomics (TXG) Financial Statements
Price: $7.58
Market Cap: $927.05M
Avg Volume: 2.98M
Market Cap: $927.05M
Avg Volume: 2.98M
Country: US
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of 10x Genomics.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $610.78M | $618.73M | $516.41M | $490.49M | $298.85M | $245.89M | $146.31M | $71.08M |
| Cost of Revenue | $196.30M | $209.41M | $120.39M | $74.09M | $58.47M | $61.03M | $28.66M | $10.56M |
| Gross Profit | $414.48M | $409.31M | $396.02M | $416.40M | $240.38M | $184.86M | $117.65M | $60.52M |
| Gross Profit Ratio | 67.86% | 66.15% | 76.69% | 84.89% | 80.44% | 75.18% | 80.41% | 85.14% |
| Research and Development Expenses | $264.70M | $270.33M | $265.67M | $211.75M | $123.38M | $83.10M | $47.54M | $32.16M |
| General and Administrative Expenses | $- | $340.03M | $294.60M | $252.86M | $200.43M | $129.33M | $87.24M | $46.54M |
| Selling and Marketing Expenses | $- | $3.30M | $3.70M | $4.70M | $1.90M | $1.50M | $700.00K | $200.00K |
| Selling General and Administrative Expenses | $344.34M | $343.33M | $298.30M | $257.56M | $202.33M | $130.83M | $87.94M | $46.74M |
| Other Expenses | $- | $- | $-198.00K | $-802.00K | $1.34M | $-186.00K | $-249.00K | $137.00K |
| Operating Expenses | $609.04M | $674.95M | $563.97M | $469.31M | $325.70M | $213.93M | $135.47M | $78.90M |
| Cost and Expenses | $805.34M | $884.36M | $684.35M | $543.40M | $384.17M | $274.96M | $164.13M | $89.46M |
| Interest Income | $18.45M | $16.91M | $6.65M | $206.00K | $1.53M | $2.81M | $1.02M | $308.00K |
| Interest Expense | $4.00K | $33.00K | $476.00K | $866.00K | $1.68M | $3.08M | $2.41M | $811.00K |
| Depreciation and Amortization | $43.71M | $43.62M | $33.01M | $28.25M | $19.02M | $7.07M | $3.90M | $4.30M |
| EBITDA | $-133.99M | $-205.11M | $-128.49M | $-24.59M | $-513.77M | $-20.89M | $-106.08M | $-13.62M |
| EBITDA Ratio | -21.94% | -33.15% | -24.88% | -5.01% | -171.92% | -8.49% | -72.50% | -19.17% |
| Operating Income | $-194.56M | $-194.95M | $-167.94M | $-52.91M | $-85.32M | $-29.07M | $-110.76M | $-18.38M |
| Operating Income Ratio | -31.85% | -31.51% | -32.52% | -10.79% | -28.55% | -11.82% | -75.70% | -25.85% |
| Total Other Income Expenses Net | $16.86M | $-53.81M | $5.97M | $-802.00K | $-449.15M | $-1.96M | $-1.63M | $-366.00K |
| Income Before Tax | $-177.70M | $-248.76M | $-161.97M | $-53.72M | $-534.48M | $-31.03M | $-112.40M | $-18.74M |
| Income Before Tax Ratio | -29.09% | -40.21% | -31.36% | -10.95% | -178.85% | -12.62% | -76.82% | -26.36% |
| Income Tax Expense | $4.93M | $6.34M | $4.03M | $4.51M | $8.26M | $218.00K | $87.00K | $21.00K |
| Net Income | $-182.63M | $-255.10M | $-166.00M | $-58.22M | $-542.73M | $-31.25M | $-112.48M | $-18.76M |
| Net Income Ratio | -29.90% | -41.23% | -32.15% | -11.87% | -181.61% | -12.71% | -76.88% | -26.39% |
| EPS | $-1.52 | $-2.18 | $-1.46 | $-0.53 | $-5.37 | $-0.80 | $-8.40 | $-1.62 |
| EPS Diluted | $-1.52 | $-2.18 | $-1.46 | $-0.53 | $-5.37 | $-0.80 | $-8.40 | $-1.62 |
| Weighted Average Shares Outstanding | 120.45M | 117.17M | 113.86M | 110.35M | 101.15M | 39.06M | 13.39M | 11.59M |
| Weighted Average Shares Outstanding Diluted | 120.45M | 117.17M | 113.86M | 110.35M | 101.15M | 39.09M | 13.39M | 11.59M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $344.07M | $359.28M | $219.75M | $587.45M | $663.60M | $424.17M | $65.08M | $47.86M |
| Short Term Investments | $49.34M | $29.41M | $210.24M | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $393.40M | $388.69M | $429.98M | $587.45M | $663.60M | $424.17M | $65.08M | $47.86M |
| Net Receivables | $87.86M | $114.83M | $104.21M | $85.25M | $51.21M | $33.37M | $28.09M | $13.34M |
| Inventory | $83.11M | $73.71M | $81.63M | $59.97M | $29.96M | $15.27M | $8.57M | $4.84M |
| Other Current Assets | $20.02M | $18.79M | $19.21M | $28.82M | $42.62M | $16.07M | $4.50M | $4.14M |
| Total Current Assets | $584.39M | $596.02M | $635.03M | $747.59M | $774.37M | $480.84M | $106.24M | $68.11M |
| Property Plant Equipment Net | $309.94M | $344.93M | $359.21M | $230.41M | $119.82M | $48.82M | $11.13M | $6.92M |
| Goodwill | $4.51M | $4.51M | $4.51M | $4.51M | $- | $- | $- | $- |
| Intangible Assets | $15.67M | $16.62M | $22.86M | $25.40M | $22.35M | $22.37M | $- | $- |
| Goodwill and Intangible Assets | $20.18M | $21.13M | $27.37M | $29.91M | $22.35M | $22.37M | $- | $- |
| Long Term Investments | $- | $- | $4.97M | $7.60M | $8.47M | $52.33M | $5.01M | $- |
| Tax Assets | $- | $- | $-4.97M | $-7.60M | $-8.47M | $-74.69M | $- | $- |
| Other Non-Current Assets | $4.13M | $3.06M | $7.37M | $10.92M | $12.80M | $76.26M | $1.94M | $577.00K |
| Total Non-Current Assets | $334.25M | $369.12M | $393.94M | $271.24M | $154.97M | $125.08M | $18.07M | $7.50M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $918.64M | $965.14M | $1.03B | $1.02B | $929.34M | $605.92M | $124.31M | $75.61M |
| Account Payables | $12.91M | $15.74M | $21.60M | $17.35M | $4.71M | $13.03M | $8.79M | $5.44M |
| Short Term Debt | $9.29M | $11.52M | $18.07M | $10.26M | $11.87M | $9.88M | $4.19M | $4.22M |
| Tax Payables | $4.94M | $5.05M | $4.08M | $4.62M | $8.65M | $1.09M | $738.00K | $163.00K |
| Deferred Revenue | $20.66M | $13.15M | $7.87M | $5.34M | $4.47M | $3.30M | $2.78M | $1.83M |
| Other Current Liabilities | $69.84M | $81.70M | $79.34M | $72.78M | $88.42M | $35.76M | $16.25M | $11.20M |
| Total Current Liabilities | $117.63M | $127.16M | $130.96M | $110.36M | $118.13M | $63.05M | $32.36M | $22.14M |
| Long Term Debt | $73.33M | $83.85M | $172.28M | $153.69M | $114.08M | $19.84M | $25.49M | $6.33M |
| Deferred Revenue Non-Current | $- | $8.81M | $3.17M | $- | $- | $834.00K | $1.10M | $713.00K |
| Deferred Tax Liabilities Non-Current | $- | $- | $-3.17M | $- | $- | $101.03M | $284.57M | $158.41M |
| Other Non-Current Liabilities | $17.54M | $4.28M | $-80.00M | $-62.79M | $-41.94M | $102.12M | $771.00K | $514.00K |
| Total Non-Current Liabilities | $90.87M | $96.94M | $92.28M | $90.90M | $72.14M | $122.79M | $311.94M | $165.98M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $208.50M | $224.10M | $223.24M | $201.26M | $190.27M | $185.84M | $344.30M | $188.12M |
| Preferred Stock | $- | $- | $- | $- | $- | $605.92M | $243.24M | $158.41M |
| Common Stock | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $1.00K | $1.00K |
| Retained Earnings | $-1.47B | $-1.28B | $-1.03B | $-863.32M | $-805.10M | $-262.37M | $-231.12M | $-118.63M |
| Accumulated Other Comprehensive Income Loss | $-493.00K | $-429.00K | $-4.33M | $22.00K | $-50.00K | $-46.00K | $-37.00K | $-15.00K |
| Other Total Stockholders Equity | $2.18B | $2.03B | $1.84B | $1.68B | $1.54B | $682.49M | $11.16M | $6.14M |
| Total Stockholders Equity | $710.13M | $741.04M | $805.74M | $817.57M | $739.07M | $420.08M | $-219.99M | $-112.51M |
| Total Equity | $710.13M | $741.04M | $805.74M | $817.57M | $739.07M | $420.08M | $-219.99M | $-112.51M |
| Total Liabilities and Stockholders Equity | $918.64M | $965.14M | $1.03B | $1.02B | $929.34M | $605.92M | $124.31M | $75.61M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $918.64M | $965.14M | $1.03B | $1.02B | $929.34M | $605.92M | $124.31M | $75.61M |
| Total Investments | $49.34M | $29.41M | $210.24M | $7.60M | $8.47M | $52.33M | $5.01M | $- |
| Total Debt | $82.61M | $95.37M | $95.18M | $81.98M | $62.98M | $29.72M | $29.68M | $10.56M |
| Net Debt | $-261.45M | $-263.91M | $-124.57M | $-505.47M | $-600.62M | $-394.45M | $-35.40M | $-37.30M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-182.63M | $-255.10M | $-166.00M | $-58.22M | $-542.73M | $-31.25M | $-112.48M | $-18.76M |
| Depreciation and Amortization | $43.71M | $43.62M | $33.01M | $28.25M | $19.02M | $7.07M | $3.90M | $4.30M |
| Deferred Income Tax | $- | $- | $- | $- | $1.55M | $614.00K | $251.00K | $- |
| Stock Based Compensation | $140.75M | $166.95M | $136.85M | $95.96M | $48.63M | $13.33M | $2.66M | $1.66M |
| Change in Working Capital | $1.25M | $17.34M | $-39.42M | $-87.44M | $-50.38M | $44.76M | $28.02M | $1.95M |
| Accounts Receivables | $26.95M | $-10.61M | $-18.95M | $-34.04M | $-17.85M | $-5.28M | $-14.75M | $-5.13M |
| Inventory | $-9.78M | $7.87M | $-21.19M | $-30.13M | $-14.60M | $-6.70M | $-3.73M | $-2.00M |
| Accounts Payables | $-3.35M | $-6.02M | $5.86M | $11.08M | $-7.77M | $4.90M | $2.59M | $3.03M |
| Other Working Capital | $-12.57M | $26.10M | $-5.13M | $-34.36M | $-10.16M | $51.85M | $43.91M | $6.04M |
| Other Non Cash Items | $3.58M | $11.99M | $1.96M | $79.00K | $306.02M | $101.00K | $1.25M | $149.00K |
| Net Cash Provided by Operating Activities | $6.66M | $-15.20M | $-33.61M | $-21.37M | $-217.90M | $34.63M | $-76.41M | $-10.70M |
| Investments in Property Plant and Equipment | $-12.39M | $-48.60M | $-131.66M | $-101.28M | $-38.39M | $-42.77M | $-6.71M | $-3.76M |
| Acquisitions Net | $- | $- | $-4.00M | $-5.45M | $- | $- | $- | $- |
| Purchases of Investments | $-48.88M | $- | $-282.87M | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $29.64M | $183.02M | $67.64M | $- | $- | $- | $- | $- |
| Other Investing Activities | $-1.00M | $-923.00K | $-215.23M | $- | $-1.73M | $-25.00K | $-425.00K | $- |
| Net Cash Used for Investing Activities | $-32.63M | $133.49M | $-350.89M | $-106.73M | $-38.39M | $-42.77M | $-6.71M | $-3.76M |
| Debt Repayment | $- | $- | $- | $- | $-37.10M | $- | $18.74M | $-393.00K |
| Common Stock Issued | $- | $19.48M | $21.23M | $40.33M | $482.27M | $410.82M | $1.80M | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $-80.00K |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $10.91M | $13.67M | $15.82M | $35.30M | $23.74M | $3.77M | $86.63M | $21.06M |
| Net Cash Used Provided by Financing Activities | $10.91M | $13.67M | $15.82M | $35.30M | $468.91M | $414.59M | $105.37M | $20.58M |
| Effect of Forex Changes on Cash | $-164.00K | $-33.00K | $-44.00K | $234.00K | $-463.00K | $-45.00K | $-18.00K | $-14.00K |
| Net Change in Cash | $-15.22M | $131.93M | $-368.72M | $-92.57M | $212.15M | $406.40M | $22.23M | $6.11M |
| Cash at End of Period | $344.07M | $359.28M | $227.35M | $596.07M | $688.64M | $476.49M | $70.09M | $47.86M |
| Cash at Beginning of Period | $359.28M | $227.35M | $596.07M | $688.64M | $476.49M | $70.09M | $47.86M | $41.74M |
| Operating Cash Flow | $6.66M | $-15.20M | $-33.61M | $-21.37M | $-217.90M | $34.63M | $-76.41M | $-10.70M |
| Capital Expenditure | $-12.39M | $-49.52M | $-131.66M | $-101.28M | $-38.39M | $-42.77M | $-6.71M | $-3.76M |
| Free Cash Flow | $-5.73M | $-64.72M | $-165.27M | $-122.65M | $-256.29M | $-8.14M | $-83.12M | $-14.46M |